In summary, we explored the role of RALYL in HCC development and demonstrated that RALYL could increase the stemness of HCC through TGF-β2 signaling, which could help us to unveil the molecular mechanism of CSCs and inspire strategies targeting to CSCs. This evidence concerns the gene TGFB2 and hepatocellular carcinoma.